SCHEMBL6664554

SCHEMBL6664554

CN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3CCC(O)(P(=O)(O)O)P(=O)(O)O)CC1

nearest known ligand 0.74

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.74
▸ DRD3 P35462 1/20 0.71
▸ KDM4E B2RXH2 8/20 0.65
▸ MEN1 O00255 7/20 0.65
▸ KMT2A Q03164 7/20 0.65
▸ HPGD P15428 3/20 0.65
▸ NPC1 O15118 1/20 0.65
▸ GAA P10253 1/20 0.59
▸ RAD52 P43351 1/20 0.59
▸ LMNA P02545 3/20 0.59
▸ HSD17B10 Q99714 2/20 0.59
▸ BRD4 O60885 1/20 0.59
▸ TSHR P16473 1/20 0.59
▸ HTT P42858 1/20 0.59
▸ CYP2J2 P51589 1/20 0.59
▸ NPSR1 Q6W5P4 1/20 0.59
▸ GLA P06280 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6667765 0.89 KDM4E (0.60) ALDH1A1DRD3KDM4EMEN1KMT2A
SCHEMBL6665831 0.88 ALDH1A1 (0.57) ALDH1A1DRD3KDM4EMEN1KMT2A
SCHEMBL7809357 0.85 ALDH1A1 (1.00) ALDH1A1DRD3KDM4EMEN1KMT2A
SCHEMBL29388444 0.85 ALDH1A1 (1.00) ALDH1A1DRD3KDM4EMEN1KMT2A
SCHEMBL11391733 0.84 ALDH1A1 (0.86) ALDH1A1DRD3KDM4EMEN1KMT2A
SCHEMBL15282135 0.84 ALDH1A1 (0.86) ALDH1A1DRD3KDM4EMEN1KMT2A
SCHEMBL5679721 0.84 ALDH1A1 (0.75) ALDH1A1DRD3KDM4EMEN1KMT2A
Pefloxacin SCHEMBL34292 0.83 DRD3 (1.00) ALDH1A1DRD3KDM4EMEN1KMT2A
Pefloxacin SCHEMBL29351730 0.83 DRD3 (1.00) ALDH1A1DRD3KDM4EMEN1KMT2A
Pefloxacin SCHEMBL28251251 0.83 DRD3 (1.00) ALDH1A1DRD3KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0831845-B1 DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS ELIZANOR BIOPHARMACEUTICALS IN (US) 2004-09-08 — — EP claimed
WO-1996040156-A1 DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS ELIZANOR BIOPHARMACEUTICALS, INC. (US) 1996-12-19 — — WO claimed
EP-0831845-B1 DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS ELIZANOR BIOPHARMACEUTICALS IN (US) 2004-09-08 — — EP disclosed
US-5854227-A Therapeutic derivatives of diphosphonates ELIZANOR BIOPHARMACUETICALS, INC. 1998-12-29 — — US disclosed
WO-1996040156-A1 DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS ELIZANOR BIOPHARMACEUTICALS, INC. (US) 1996-12-19 — — WO disclosed
Send feedback